Analyst Ratings for WAVE Life Sciences (WVE)
WVE Rating Summary
WVE Price Target Summary
- Highest: $19.00 (Mizuho)
- Lowest: $5.00 (RBC Capital)
- Average: $12.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.20 (+157.4%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 65%
Avg. $ Target:
$12.20 (+157.4%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2023 | Leerink Partners | Joseph P. Schwartz | Upgrade | Outperform (Market Perform) |
12.00 (5.00) |
4.49 (4.74) |
5.57% | Details |
| 7/5/2023 | Raymond James » Updated 3/6/2024 |
Steven Seedhouse | New Coverage | Outperform (N/A) |
10.00 (7.00) |
3.56 (4.74) |
33.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
